Chemed (NYSE:CHE) Issues Earnings Results

Chemed (NYSE:CHE - Get Free Report) announced its earnings results on Wednesday. The company reported $6.30 earnings per share for the quarter, missing the consensus estimate of $6.78 by ($0.48), Zacks reports. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company had revenue of $639.99 million during the quarter, compared to analysts' expectations of $636.10 million. Chemed updated its FY 2025 guidance to 24.950-25.450 EPS.

Chemed Stock Performance

Chemed stock traded up $14.34 during trading on Friday, hitting $600.46. The company's stock had a trading volume of 141,070 shares, compared to its average volume of 96,197. The stock's fifty day moving average is $546.69 and its 200 day moving average is $563.39. Chemed has a 1-year low of $512.12 and a 1-year high of $654.62. The stock has a market capitalization of $9.04 billion, a price-to-earnings ratio of 30.34, a P/E/G ratio of 2.15 and a beta of 0.48.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.33%. Chemed's payout ratio is currently 10.05%.

Analyst Ratings Changes

A number of analysts recently weighed in on CHE shares. Royal Bank of Canada decreased their price target on Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research note on Tuesday, November 5th. StockNews.com cut Chemed from a "buy" rating to a "hold" rating in a report on Thursday.

Remove Ads

Insider Buying and Selling at Chemed

In other news, VP Brian C. Judkins purchased 145 shares of the stock in a transaction on Monday, December 30th. The stock was purchased at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the transaction, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. The trade was a 9.46 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 3.32% of the stock is owned by company insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.